Find verified Latrepirdine dihydrochloride API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Latrepirdine dihydrochloride for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Latrepirdine dihydrochloride API.
Alternate Names: Dimebolin dihydrochloride, Dimebon HCl
CAS No: 97657-92-6
PubChem CID: 23729232
Mol Formula: C21H27Cl2N3
Mol Weight: 392.40 g/mol
IUPAC Name: 2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-3,4-dihydro-1H-pyrido[4,3-b]indole;dihydrochloride
Commercial / Development Status: Discontinued
Source / Manufacturing Origin: Synthetic
API Description: Latrepirdine Dihydrochloride, also known as Dimebon, was investigated as a treatment for neurodegenerative diseases like Alzheimer's and Huntington's disease, with potential mechanisms including autophagy enhancement and mitochondrial stabilization. However, due to negative results in clinical trials, latrepirdine remains unlicensed and not approved for use in treating these or any other neurodegenerative conditions.
